This project of the duration of 18 months is focussed at the in vitro and in vivo characterization of a novel NK-1 antagonist. Calò G. principal investigator Project sponsored by Helsinn pharma
Pharmacological profile of netupitant
CALO', Girolamo
2009
Abstract
This project of the duration of 18 months is focussed at the in vitro and in vivo characterization of a novel NK-1 antagonist. Calò G. principal investigator Project sponsored by Helsinn pharmaFile in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
